EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hürthle cell (Oncocytic) carcinoma – Is hemithyroidectomy enough?

Taylor O. Julsrud, Trenton R. Foster, Robert A. Vierkant, Melanie L. Lyden, Travis J. McKenzie, Mabel Ryder, Benzon M. Dy

Surgical Oncology Insight · 2024-03 · 1 (1) · 100010

DOI: 10.1016/j.soi.2024.100010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Surgical Oncology Insight, 2024-03. Verfasst von Taylor O. Julsrud und 6 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Julsrud, T. O., Foster, T. R., Vierkant, R. A., Lyden, M. L., McKenzie, T. J., Ryder, M., & Dy, B. M. (2024). Hürthle cell (Oncocytic) carcinoma – Is hemithyroidectomy enough?. Surgical Oncology Insight, 1(1), 100010. https://doi.org/10.1016/j.soi.2024.100010

Vancouver

Julsrud TO, Foster TR, Vierkant RA, Lyden ML, McKenzie TJ, Ryder M, et al. Hürthle cell (Oncocytic) carcinoma – Is hemithyroidectomy enough?. Surgical Oncology Insight. 2024;1(1):100010. doi:10.1016/j.soi.2024.100010

BibTeX
@article{Julsrud2024,
  author = {Julsrud, Taylor O. and Foster, Trenton R. and Vierkant, Robert A. and Lyden, Melanie L. and McKenzie, Travis J. and Ryder, Mabel and Dy, Benzon M.},
  title = {Hürthle cell (Oncocytic) carcinoma – Is hemithyroidectomy enough?},
  journal = {Surgical Oncology Insight},
  year = {2024},
  volume = {1},
  number = {1},
  pages = {100010},
  doi = {10.1016/j.soi.2024.100010}
}
Kostenlos starten →